J. Vercouillie

J. Vercouillie, C. Ali, D. Vivien, 2022, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Development and preclinical evaluation of [18F]FBVM as a new potent PET tracer for vesicular acetylcholine transporter.

J. Vercouillie, D. Guilloteau, A. Chartier, 2022, European journal of medicinal chemistry.

Bis(het)aryl-1,2,3-triazole quinuclidines as α7 nicotinic acetylcholine receptor ligands: Synthesis, structure affinity relationships, agonism activity, [18F]-radiolabeling and PET study in rats.

J. Vercouillie, D. Guilloteau, G. Page, 2019, European journal of medicinal chemistry.

Design of α7 nicotinic acetylcholine receptor ligands using the (het)Aryl-1,2,3-triazole core: Synthesis, in vitro evaluation and SAR studies.

J. Vercouillie, D. Guilloteau, Emilie Bertrand, 2016, European journal of medicinal chemistry.

Design of α7 nicotinic acetylcholine receptor ligands in quinuclidine, tropane and quinazoline series. Chemistry, molecular modeling, radiochemistry, in vitro and in rats evaluations of a [(18)F] quinuclidine derivative.

J. Vercouillie, D. Guilloteau, C. Jarry, 2014, European journal of medicinal chemistry.

Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.

A. Ravna, J. Vercouillie, D. Guilloteau, 2008, Bioorganic & medicinal chemistry.

Synthesis of tropane and nortropane analogues with phenyl substitutions as serotonin transporter ligands.

J. Vercouillie, D. Guilloteau, P. Emond, 2001, Bioorganic & medicinal chemistry.

Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.

R. Innis, M. Kassiou, J. Vercouillie, 2006, Bioorganic & medicinal chemistry letters.

Neuroimaging of the vesicular acetylcholine transporter by a novel 4-[18F]fluoro-benzoyl derivative of 7-hydroxy-6-(4-phenyl-piperidin-1-yl)-octahydro-benzo[1,4]oxazines.

M. Scheunemann, J. Steinbach, P. Brust, 2009, Nuclear medicine and biology.

Radiopharmaceuticals for PET imaging of neuroinflammation

M. Kassiou, J. Vercouillie, D. Guilloteau, 2016 .

Fully automated radiosynthesis of [18F]LBT999 on TRACERlab FXFN and AllinOne modules, a PET radiopharmaceutical for imaging the dopamine transporter in human brain

J. Vercouillie, D. Guilloteau, Anne-Claire Dupont, 2020, EJNMMI Radiopharmacy and Chemistry.

ADAM is an effective tool for in vivo study of serotonergic function: Validation in rat models

J. Vercouillie, D. Guilloteau, P. Emond, 2004, Synapse.

Study of influence of the glutamatergic concentration of [18F]FPEB binding to metabotropic glutamate receptor subtype 5 with N-acetylcysteine challenge in rats and SRM/PET study in human healthy volunteers

J. Vercouillie, C. Tauber, Anne-Claire Dupont, 2021, Translational Psychiatry.

Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [18F] PET tracer

J. Vercouillie, D. Guilloteau, N. Arlicot, 2018, Journal of enzyme inhibition and medicinal chemistry.

Glutamatergic synapse in autism: a complex story for a complex disorder

S. Roux, J. Vercouillie, C. Belzung, 2022, Molecular Psychiatry.

Aromatic fluoro-de-triazenation with boron trifluoride diethyl etherate under non-protic acid conditions

J. Vercouillie, D. Guilloteau, M. Kovač, 2013 .

Tandem Silver‐Catalyzed Cyclization/Nucleophilic Functionalization of 2‐Alkynylindole‐3‐carbaldehyde Oximes to Afford New 2,4‐Disubstituted γ‐Carbolines

J. Vercouillie, D. Guilloteau, S. Routier, 2016 .

Aromatic Fluoro‐de‐triazenation with Boron Trifluoride Diethyl Etherate under Non‐protic Acid Conditions.

J. Vercouillie, D. Guilloteau, M. Kovač, 2013 .

13th Workshop of the Central European Division e.V. of the International Isotope Society

M. Scheunemann, J. Steinbach, J. Herbert, 2006 .

Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study

Stephen R. Williams, F. Edwards, J. Rinne, 2021, Theranostics.

EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging quality

Y. Seimbille, A. Gee, J. Vercouillie, 2021, EJNMMI Radiopharmacy and Chemistry.

Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment

K. Mondon, J. Cottier, J. Vercouillie, 2020, Frontiers in Neurology.

[ 18 F]‐labeled positron emission tomography ligand for the histamine H4 receptor

J. Vercouillie, S. Chalon, S. Routier, 2021, Journal of Labelled Compounds and Radiopharmaceuticals.

EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)

B. Gulyás, G. Bormans, A. Gee, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Assessment of the Protection of Dopaminergic Neurons by an α7 Nicotinic Receptor Agonist, PHA 543613 Using [18F]LBT-999 in a Parkinson’s Disease Rat Model

J. Vercouillie, D. Guilloteau, G. Page, 2015, Front. Med..

Synthesis of 1‐Tetralone Derivatives Using a Stille Cross Coupling/Friedel Crafts Acylation Sequence

J. Vercouillie, J. Parrain, M. Abarbri, 2004 .

The Pattern of Brain Amyloid Load in Posterior Cortical Atrophy Using 18F-AV45: Is Amyloid the Principal Actor in the Disease?

C. Hommet, K. Mondon, J. Cottier, 2014, Dementia and Geriatric Cognitive Disorders Extra.

Synthesis and in vitro evaluation of new diphenyl ether derivatives as serotonin transporter ligands

J. Steinbach, P. Brust, J. Vercouillie, 2008 .

Brain [18F]FDDNP binding and glucose metabolism in advanced elderly healthy subjects and Alzheimer's disease patients.

Denis Guilloteau, Clovis Tauber, Johnny Vercouillie, 2013, Journal of Alzheimer's disease : JAD.

Automated production of [18F]FDDNP using a TRACERlab MXFDG

J. Vercouillie, L. Barré, C. Prenant, 2010 .

Automated production of ( 18 F)FDDNP using a TRACERlab MX FDG

J. Vercouillie, L. Barré, D. Guilloteau, 2010 .

Could 18 F-DPA-714 PET imaging be interesting to use in the early post-stroke period?

M. Kassiou, J. Cottier, J. Vercouillie, 2014, EJNMMI Research.

Pharmacological Characterization ofN,N-Dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a Ligand of the Serotonin Transporter with High Affinity and Selectivity

Denis Guilloteau, Christer Halldin, Lars Farde, 2003, Journal of Pharmacology and Experimental Therapeutics.

Identification of new molecular targets for PET imaging of the microglial anti-inflammatory activation state

B. Jego, A. Windhorst, A. Planas, 2018, Theranostics.

Identification of new molecular targets for PET imaging of microglial anti-inflammatory phenotype

Sironi, Luigi, G. Bormans, 2017 .

Application of advanced brain positron emission tomography–based molecular imaging for a biological framework in neurodegenerative proteinopathies

Paul Edison, Matthias M. Herth, Michael A. Carroll, 2019, Alzheimer's & dementia.

Extensive exploration of a novel rat model of Parkinson's disease using partial 6‐hydroxydopamine lesion of dopaminergic neurons suggests new therapeutic approaches

J. Vercouillie, C. Tronel, F. Dollé, 2018, Synapse.

New fluoro-diphenylchalcogen derivatives to explore the serotonin transporter by PET.

M. Scheunemann, J. Steinbach, P. Brust, 2007, Bioorganic & medicinal chemistry letters.

Training the next generation of radiopharmaceutical scientists.

Ephraim E. Parent, H. Kung, E. Hostetler, 2020, Nuclear medicine and biology.

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

J. Passchier, J. Vercouillie, M. Patt, 2023, EJNMMI Radiopharmacy and Chemistry.

Precursor synthesis and radiolabelling of [11C]ADAM: a potential radioligand for the serotonin transporter exploration by PET

J. Sandell, C. Halldin, J. Vercouillie, 2001 .

Detection of Neuroinflammation in a Rat Model of Subarachnoid Hemorrhage Using [18F]DPA-714 PET Imaging

M. Kassiou, C. Destrieux, J. Vercouillie, 2016, Molecular imaging.

Amyloid load and TSPO in APPswePS 1-dE 9 mice : a longitudinal study

M. Kassiou, J. Vercouillie, D. Guilloteau, 2015 .

Metabotropic Glutamate Receptor Subtype 5 Positron-Emission-Tomography Radioligands as a Tool for Central Nervous System Drug Development: Between Progress and Setbacks

J. Vercouillie, F. Bonnet-Brilhault, Anne-Claire Dupont, 2023, Pharmaceuticals.

Carbon-11 labelling of MADAM in two different positions: a highly selective PET radioligand for the serotonin transporter

Denis Guilloteau, Christer Halldin, Patrick Emond, 2001 .

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment

B. Vellas, G. Chételat, B. Desgranges, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Development and preclinical evaluation of [18F]FBVM as a new potent PET tracer for vesicular acetylcholine transporter.

J. Vercouillie, D. Guilloteau, A. Chartier, 2022, European journal of medicinal chemistry.

Imaging of the Striatal and Extrastriatal Dopamine Transporter with 18F-LBT-999: Quantification, Biodistribution, and Radiation Dosimetry in Nonhuman Primates

Denis Guilloteau, Christer Halldin, Vladimir Stepanov, 2011, The Journal of Nuclear Medicine.